The emerging approach of this peptide represents a significant advance in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide335559.blogadvize.com/50608838/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment